Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:CWEBNYSE:HEXONYSE:MDPTSE:VPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCWEBDirexion Daily CSI China Internet Index Bull 2x Shares$39.97+0.9%$38.47$24.60▼$59.31$254.61M0.62735,505 shs283,508 shsHEXOHEXO$0.71+2.5%$0.87$0.66▼$3.84$31.24M1.35880,508 shs305,500 shsMDPMeredith$58.78$18.00▼$59.16$2.70B2.07552,848 shs3.36 million shsVPHValeo PharmaC$0.05C$0.04▼C$0.39C$4.44M2.3259,093 shs51,000 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCWEBDirexion Daily CSI China Internet Index Bull 2x Shares0.00%+6.99%+10.17%-7.18%+31.65%HEXOHEXO0.00%0.00%0.00%0.00%0.00%MDPMeredith0.00%0.00%0.00%0.00%0.00%VPHValeo Pharma0.00%0.00%0.00%0.00%-57.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCWEBDirexion Daily CSI China Internet Index Bull 2x SharesN/AN/AN/AN/AN/AN/AN/AN/AHEXOHEXON/AN/AN/AN/AN/AN/AN/AN/AMDPMeredithN/AN/AN/AN/AN/AN/AN/AN/AVPHValeo PharmaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCWEBDirexion Daily CSI China Internet Index Bull 2x Shares 0.00N/AN/AN/AHEXOHEXO 0.00N/AN/AN/AMDPMeredith 0.00N/AN/AN/AVPHValeo Pharma 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCWEBDirexion Daily CSI China Internet Index Bull 2x SharesN/AN/AN/AN/AN/AN/AHEXOHEXO$146.20M0.21N/AN/A$2.44 per share0.29MDPMeredith$2.98B0.00N/A5.68$14.27 per share0.00VPHValeo PharmaC$53.38M0.00N/AN/AC($0.64) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCWEBDirexion Daily CSI China Internet Index Bull 2x SharesN/AN/A17.82∞N/AN/AN/AN/AN/AHEXOHEXO-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%N/AMDPMeredith$306.60M$5.9010.01N/AN/A9.66%41.72%4.92%N/AVPHValeo Pharma-C$32.12M-C$0.37N/AN/AN/A-60.18%N/A-26.07%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCWEBDirexion Daily CSI China Internet Index Bull 2x Shares$1.172.93%N/AN/AN/AHEXOHEXON/AN/AN/AN/AN/AMDPMeredithN/AN/AN/AN/AN/AVPHValeo PharmaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCWEBDirexion Daily CSI China Internet Index Bull 2x SharesN/AN/AN/AHEXOHEXO0.010.410.24MDPMeredith4.031.391.36VPHValeo PharmaN/A0.27N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCWEBDirexion Daily CSI China Internet Index Bull 2x SharesN/AHEXOHEXO7.78%MDPMeredith78.23%VPHValeo Pharma7.24%Insider OwnershipCompanyInsider OwnershipCWEBDirexion Daily CSI China Internet Index Bull 2x SharesN/AHEXOHEXO4.69%MDPMeredith9.79%VPHValeo Pharma47.12%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCWEBDirexion Daily CSI China Internet Index Bull 2x SharesN/A6.37 millionN/ANot OptionableHEXOHEXO1,27744.00 million41.93 millionOptionableMDPMeredith5,33045.78 million41.30 millionOptionableVPHValeo Pharma10098.66 millionN/ANot OptionableHEXO, MDP, CWEB, and VPH HeadlinesRecent News About These CompaniesValeo Pharma announces the closing of a share purchase agreement with Xediton Pharmaceuticals Inc.February 6, 2025 | finance.yahoo.comValeo: Weak Auto Markets And EV Uncertainties Continue To Hit HardOctober 31, 2024 | seekingalpha.comValeo Pharma Inc.: Valeo Pharma Reports Third Quarter 2024 RevenuesOctober 5, 2024 | finanznachrichten.deCanadian Investment Regulatory Organization Trading Halt - VPHOctober 2, 2024 | finance.yahoo.comVALEO PHARMA INITIATES RESTRUCTURING PROCEEDINGS UNDER THE CCAA TO IMPLEMENT A REVIEW OF ITS STRATEGIC ALTERNATIVESOctober 1, 2024 | finance.yahoo.comVALEO PHARMA REPORTS THIRD QUARTER 2024 REVENUESSeptember 13, 2024 | finance.yahoo.comVALEO PHARMA TO HOST THIRD QUARTER 2024 RESULTS CONFERENCE CALL / WEBCASTSeptember 9, 2024 | ca.finance.yahoo.comValeo Pharma Inc. (VPH.TO)September 6, 2024 | ca.finance.yahoo.comBay Street Likely To Open On Weak NoteSeptember 4, 2024 | nasdaq.comVALEO PHARMA AMENDS CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LPSeptember 4, 2024 | finance.yahoo.comVALEO PHARMA ANNOUNCES VOLUNTARY DELISTING FROM OTCQB VENTURE MARKETAugust 29, 2024 | finance.yahoo.comVALEO PHARMA ANNOUNCES LEADERSHIP CHANGESAugust 6, 2024 | newswire.caClosing Bell: Valeo Pharma Inc 12.0 Pct Debs down on Monday (VPH-DB)July 20, 2024 | theglobeandmail.comBullish Valeo Pharma Insiders Loaded Up On CA$1.20m Of StockMay 5, 2024 | finance.yahoo.comVALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCEApril 9, 2024 | finance.yahoo.comValeo Pharma: Top 25 Undervalued Toronto Stock Exchange Stocks (VPH)April 1, 2024 | theglobeandmail.comVALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORSMarch 22, 2024 | finance.yahoo.comValeo Pharma’s Strategic Moves Signal Potential for EBITDA Positivity and Stock CatalystsMarch 16, 2024 | markets.businessinsider.comValeo Pharma sees 1Q revenue increase on strong performance from respiratory divisionMarch 15, 2024 | proactiveinvestors.co.ukVALEO PHARMA REPORTS FIRST QUARTER 2024 RESULTSMarch 14, 2024 | finance.yahoo.comHEXO, MDP, CWEB, and VPH Company DescriptionsDirexion Daily CSI China Internet Index Bull 2x Shares NYSEARCA:CWEB$39.97 +0.37 (+0.93%) Closing price 06/27/2025 04:10 PM EasternExtended Trading$39.98 +0.01 (+0.03%) As of 06/27/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Direxion Daily CSI China Internet Bull 2X Shares (CWEB) is an exchange-traded fund that is based on the CSI Overseas China Internet index. The fund provides 2x leveraged daily exposure to an index composed of overseas-listed Chinese internet companies. CWEB was launched on Nov 2, 2016 and is managed by Direxion.HEXO NYSE:HEXOHEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.Meredith NYSE:MDPMeredith Corp. engages in television broadcasting and magazine advertising business. It operates through the Local Media and National Media business segments. The Local Media segment includes television stations and offers websites, mobile-optimized websites, and mobile applications. The National Media segment consists of national consumer media brands delivered via multiple media platforms including print magazines and digital and mobile media, brand licensing activities, database-related activities, and business-to-business marketing products and services. The company was founded by Edwin Thomas Meredith in 1902 and is headquartered in Des Moines, IA.Valeo Pharma TSE:VPHValeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada. Its product portfolio includes Enerzair Breezhaler, a LABA/LAMA/ICS fixed triple dose asthma drug; Atectura Breezhaler, a LABA/ICS dual combination asthma drug; Redesca, to treat and prevent deep vein thrombosis and pulmonary embolism; Onstryv, for the treatment of Idiopathic Parkinson's disease; M-Eslon, extended-release morphine sulphate used for pain management; and Yondelis, a soft tissue sarcoma. It also offers Hesperco, a flavonoid formulation used for immune support; Ethacrynate Sodium; and Amikacin, an antibiotic. In addition, the company provides Ametop Gel 4% for skin anesthesia prior to injection or cannulation; Sabizabulin, an antiviral and anti-inflammatory agent for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and death; Simbrinza, ophthalmic drops to treat openangle glaucoma or ocular hypertension; Xiidra, a prescription based eye-drop to treat dry eye disease; and Allerject, a portable voice-activated epinephrine injector for emergency treatment of serious allergic reactions. Its primary therapeutic areas include respiratory/allergy, ophthalmology, neurology, oncology, and specialty products. The company was incorporated in 2003 and is based in Kirkland, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
